We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DURECT Corporation (DRRX) - free report >>
Mercury Systems Inc (MRCY) - free report >>
Zentalis Pharmaceuticals, Inc. (ZNTL) - free report >>
Image: Bigstock
New Strong Buy Stocks for January 9th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Affirm Holdings, Inc. (AFRM - Free Report) : This payment network company has seen the Zacks Consensus Estimate for its current year earnings increasing 13.1% over the last 60 days.
Affirm Holdings, Inc. Price and Consensus
Affirm Holdings, Inc. price-consensus-chart | Affirm Holdings, Inc. Quote
Zentalis Pharmaceuticals, Inc. (ZNTL - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 17.9% over the last 60 days.
Zentalis Pharmaceuticals, Inc. Price and Consensus
Zentalis Pharmaceuticals, Inc. price-consensus-chart | Zentalis Pharmaceuticals, Inc. Quote
Immatics N.V. (IMTX - Free Report) : This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 15.8% over the last 60 days.
Immatics N.V. Price and Consensus
Immatics N.V. price-consensus-chart | Immatics N.V. Quote
Mercury Systems, Inc. (MRCY - Free Report) : This technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 63.2% over the last 60 days.
Mercury Systems Inc Price and Consensus
Mercury Systems Inc price-consensus-chart | Mercury Systems Inc Quote
DURECT Corporation (DRRX - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 35.9% over the last 60 days.
DURECT Corporation Price and Consensus
DURECT Corporation price-consensus-chart | DURECT Corporation Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.